☰

Jason P. Swindle, Ph.D. - Publications

Affiliations: 
2009 Saint Louis University, St. Louis, MO, United States 
Area:
Public Health, Health Care Management
Tree Info Similar researchers PubMed Report error

35 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Albert N, Buysman E, Chang C, Swindle J. Lower Hospitalization and Total Healthcare Costs Among Patients with Heart Failure When Treated with Sacubitril/Valsartan Versus Angiotensin-Converting Enzyme Inhibitor or Angiotensin-Receptor Blocker: A Retrospective Study of Managed Care Claims Heart & Lung. 49: 211. DOI: 10.1016/J.Hrtlng.2020.02.012  0.481
2019 Albert NM, Swindle JP, Buysman EK, Chang C. Lower Hospitalization and Healthcare Costs With Sacubitril/Valsartan Versus Angiotensin-Converting Enzyme Inhibitor or Angiotensin-Receptor Blocker in a Retrospective Analysis of Patients With Heart Failure. Journal of the American Heart Association. 8: e011089. PMID 31023122 DOI: 10.1161/Jaha.118.011089  0.461
2019 Swindle JP, Xu Y, Mu Y, Solari PG. Healthcare costs among patients with hemophilia A treated with factor replacement or bypassing agents. Current Medical Research and Opinion. 1. PMID 30888200 DOI: 10.1080/03007995.2019.1596437  0.304
2018 Albert NM, Swindle JP, Buysman EK, Chang C. Patient Paid Healthcare Costs Following Initiation with Sacubitril/Valsartan in a Retrospective Claims-Based Study Journal of Cardiac Failure. 24. DOI: 10.1016/J.Cardfail.2018.07.079  0.325
2016 Obi EN, Swindle JP, Turner SJ, Russo PA, Altan A. Healthcare Costs Among Patients with Heart Failure: A Comparison of Costs between Matched Decedent and Survivor Cohorts. Advances in Therapy. PMID 27933568 DOI: 10.1007/S12325-016-0454-Y  0.44
2016 Obi EN, Swindle JP, Turner SJ, Russo PA, Altan A. Health Care Costs for Patients with Heart Failure Escalate Nearly 3-Fold in Final Months of Life. Journal of Managed Care & Specialty Pharmacy. 22: 1446-1456. PMID 27882835 DOI: 10.18553/Jmcp.2016.22.12.1446  0.443
2016 Swindle JP, Chan W, Waltman Johnson K, Becker L, Blauer-Peterson C, Altan A. Evaluation of Mortality and Readmissions following Hospitalization with Heart Failure. Current Medical Research and Opinion. 1-32. PMID 27348501 DOI: 10.1080/03007995.2016.1205972  0.479
2016 Swindle JP, Obi E, Turner S, Russo PA, Chang C, Blauer-Peterson C, Wacha L, Altan A. END OF LIFE HEALTHCARE COSTS IN HEART FAILURE: DIFFERENCES BASED ON RACE/ETHNICITY Journal of the American College of Cardiology. 67: 1408. DOI: 10.1016/S0735-1097(16)31409-7  0.307
2016 Swindle JP, Obi EN, Turner SJ, Blauer-Peterson CJ, Wacha LA, Altan A. Relationship between Heart Failure Therapy and Cost Burden of Heart Failure in a Managed Care Population Heart & Lung. 45: 374. DOI: 10.1016/J.Hrtlng.2016.05.007  0.44
2016 Swindle JP, Obi EN, Turner SJ, Russo PA, Chang C, Blauer-Peterson CJ, Wacha LA, Altan A. Healthcare Costs among Patients with Heart Failure: Comparisons between Decedents and Survivors Over One Year Journal of Cardiac Failure. 22. DOI: 10.1016/J.Cardfail.2016.06.286  0.466
2015 Swindle J, Obi EN, Turner SJ, Blauer-Peterson C, Wacha LA, Altan A. Relationship Between Heart Failure Therapy And Cost Burden Of Heart Failure In A Managed Care Population Journal of the American College of Cardiology. 65. DOI: 10.1016/S0735-1097(15)61054-3  0.469
2015 Swindle J, Turner SJ, Obi EN, Blauer-Peterson C, Wacha LA, Altan A. HEALTHCARE COSTS AND RESOURCE UTILIZATION IN HEART FAILURE: DIFFERENCES BASED ON HEART FAILURE HISTORY Journal of the American College of Cardiology. 65: A1049. DOI: 10.1016/S0735-1097(15)61049-X  0.348
2015 Swindle JP, Obi EN, Turner SJ, Russo PA, Blauer-Peterson CJ, Wacha LA, Altan A. Healthcare Costs in the Last Six Months of Life among Patients with Heart Failure Journal of Cardiac Failure. 21. DOI: 10.1016/J.Cardfail.2015.06.331  0.441
2014 Swindle JP, Ye X, Mallick R, Song R, Horstman T, Bays HE. Colesevelam, Ezetimibe, and Patients With Type 2 Diabetes Mellitus: Characteristics and Clinical Outcomes From a Health Care Database. The Annals of Pharmacotherapy. 48: 847-855. PMID 24740470 DOI: 10.1177/1060028014531737  0.349
2014 Swindle J, Johnson KW, Chan W, Becker LK, Peterson CB, Riedel A. HOSPITALIZATION CHARACTERISTICS OF RENALLY IMPAIRED PATIENTS ADMITTED WITH HEART FAILURE Journal of the American College of Cardiology. 63: A555. DOI: 10.1016/S0735-1097(14)60555-6  0.366
2010 Swindle JP, Rich MW, McCann P, Burroughs TE, Hauptman PJ. Implantable cardiac device procedures in older patients: use and in-hospital outcomes. Archives of Internal Medicine. 170: 631-7. PMID 20386008 DOI: 10.1001/Archinternmed.2010.30  0.626
2010 Hauptman PJ, Swindle JP, Masoudi FA, Burroughs TE. Underutilization of beta-blockers in patients undergoing implantable cardioverter-defibrillator and cardiac resynchronization procedures. Circulation. Cardiovascular Quality and Outcomes. 3: 204-11. PMID 20197509 DOI: 10.1161/Circoutcomes.109.880450  0.608
2009 Burroughs TE, Swindle JP, Salvalaggio PR, Lentine KL, Takemoto SK, Bunnapradist S, Brennan DC, Schnitzler MA. Increasing incidence of new-onset diabetes after transplant among pediatric renal transplant patients. Transplantation. 88: 367-73. PMID 19667939 DOI: 10.1097/Tp.0B013E3181Ae67F0  0.573
2009 Swindle J, Rich MW, McCann P, Hauptman PJ. Implantable Device Therapy in Octogenarians and Nonagenarians: Insights from a National Hospital Database Journal of Cardiac Failure. 15. DOI: 10.1016/J.Cardfail.2009.06.132  0.378
2009 Swindle J, Rich MW, Hauptman PJ. In-Hospital Mortality Associated with Device Implantation: Influence of Age and Procedural Complications Journal of Cardiac Failure. 15. DOI: 10.1016/J.Cardfail.2009.06.086  0.369
2008 Swindle J, Burroughs TE, Schnitzler MA, Hauptman PJ. Short-term mortality and cost associated with cardiac device implantation in patients hospitalized with heart failure. American Heart Journal. 156: 322-8. PMID 18657663 DOI: 10.1016/J.Ahj.2008.04.003  0.665
2008 Hauptman PJ, Swindle J, Burroughs TE, Schnitzler MA. Resource utilization in patients hospitalized with heart failure: insights from a contemporary national hospital database. American Heart Journal. 155: 978-985.e1. PMID 18513507 DOI: 10.1016/J.Ahj.2008.01.015  0.646
2008 Hauptman PJ, Swindle J, Hussain Z, Biener L, Burroughs TE. Physician attitudes toward end-stage heart failure: a national survey. The American Journal of Medicine. 121: 127-35. PMID 18261501 DOI: 10.1016/J.Amjmed.2007.08.035  0.625
2008 Hauptman PJ, Swindle J, Burroughs TE. Underutilization of Evidence-Based Medication in Patients Undergoing Cardiac Device Procedures: Hardware over Pills? Journal of Cardiac Failure. 14: S93. DOI: 10.1016/J.Cardfail.2008.06.257  0.573
2007 Burroughs TE, Lentine KL, Takemoto SK, Swindle J, Machnicki G, Hardinger K, Brennan DC, Irish WD, Schnitzler MA. Influence of early posttransplantation prednisone and calcineurin inhibitor dosages on the incidence of new-onset diabetes. Clinical Journal of the American Society of Nephrology : Cjasn. 2: 517-23. PMID 17699459 DOI: 10.2215/Cjn.00620206  0.555
2007 Burroughs TE, Swindle J, Takemoto S, Lentine KL, Machnicki G, Irish WD, Brennan DC, Schnitzler MA. Diabetic complications associated with new-onset diabetes mellitus in renal transplant recipients. Transplantation. 83: 1027-34. PMID 17452891 DOI: 10.1097/01.Tp.0000259617.21741.95  0.567
2007 Axelrod DA, Schnitzler M, Salvalaggio PR, Swindle J, Abecassis MM. The economic impact of the utilization of liver allografts with high donor risk index. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 7: 990-7. PMID 17391139 DOI: 10.1111/J.1600-6143.2006.01724.X  0.343
2007 Schnitzler M, Buchanan P, Swindle J, Lee R, Hauptman P. 7: The cost-effectiveness of increasing the supply of hearts for transplant The Journal of Heart and Lung Transplantation. 26: S63. DOI: 10.1016/J.Healun.2006.11.021  0.396
2007 Swindle J, Schnitzler MA, Burroughs TE, Hauptman PJ. The Highest Cost Heart Failure Hospitalizations: Insights from a National Hospital Database Journal of Cardiac Failure. 13: S167. DOI: 10.1016/J.Cardfail.2007.06.592  0.635
2007 Hauptman PJ, Swindle J, Burroughs TE, Schnitzler MA. High Short-Term Mortality and Cost Associated with Device Implantation in Hospitalized Heart Failure Patients Receiving Inotropic Therapy Journal of Cardiac Failure. 13: S158-S159. DOI: 10.1016/J.Cardfail.2007.06.560  0.662
2006 Hauptman PJ, Mikolajczak P, George A, Mohr CJ, Hoover R, Swindle J, Schnitzler MA. Chronic inotropic therapy in end-stage heart failure. American Heart Journal. 152: 1096.e1-8. PMID 17161059 DOI: 10.1016/J.Ahj.2006.08.003  0.441
2006 Hauptman PJ, Schnitzler MA, Swindle J, Burroughs TE. Use of nesiritide before and after publications suggesting drug-related risks in patients with acute decompensated heart failure. Jama. 296: 1877-84. PMID 17047218 DOI: 10.1001/Jama.296.15.1877  0.591
2006 Hussain Z, Swindle J, Hauptman PJ. Digoxin use and digoxin toxicity in the post-DIG trial era. Journal of Cardiac Failure. 12: 343-6. PMID 16762795 DOI: 10.1016/J.Cardfail.2006.02.005  0.462
2006 Swindle J, Schnitzler MA, Hussain Z, Takemoto S, Burroughs TE, Hauptman PJ. Biventricular Pacemaker Placement in Clinical Practice: Insights from a Managed Care Organization Database Journal of Cardiac Failure. 12: S108. DOI: 10.1016/J.Cardfail.2006.06.372  0.516
2006 Hauptman PJ, Swindle J, Schnitzler MA, Burroughs TE. Rapid De-Adoption of Nesiritide Following Adverse Publicity: Insights from a Large National Hospital Database Journal of Cardiac Failure. 12: S96-S97. DOI: 10.1016/J.Cardfail.2006.06.329  0.56
Show low-probability matches.